Terms: = Brain cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Prognosis
731 results:
1. Biomarkers for prognosis of meningioma patients: A systematic review and meta-analysis.
Aung TM; Ngamjarus C; Proungvitaya T; Saengboonmee C; Proungvitaya S
PLoS One; 2024; 19(5):e0303337. PubMed ID: 38758750
[TBL] [Abstract] [Full Text] [Related]
2. A multi-omics analysis-based model to predict the prognosis of low-grade gliomas.
Du Z; Jiang Y; Yang Y; Kang X; Yan J; Liu B; Yang M
Sci Rep; 2024 Apr; 14(1):9427. PubMed ID: 38658591
[TBL] [Abstract] [Full Text] [Related]
3. Genomic landscape of glioblastoma without IDH somatic mutation in 42 cases: a comprehensive analysis using RNA sequencing data.
Okamoto T; Mizuta R; Takahashi Y; Otani Y; Sasaki E; Horio Y; Kuroda H; Matsushita H; Date I; Hashimoto N; Masago K
J Neurooncol; 2024 May; 167(3):489-499. PubMed ID: 38653957
[TBL] [Abstract] [Full Text] [Related]
4. Molecular characterization and survival analysis of a cohort of glioblastoma, IDH-wildtype.
Dundar B; Alsawas M; Masaadeh A; Conway K; Snow AN; Sompallae RR; Bossler AD; Ma D; Lopes Abath Neto O
Pathol Res Pract; 2024 May; 257():155272. PubMed ID: 38631135
[TBL] [Abstract] [Full Text] [Related]
5. IQGAP3 promotes the progression of glioma as an immune and prognostic marker.
Gao X; Ge J; Gao X; Mei NA; Su Y; Shan S; Qian W; Guan J; Zhang Z; Wang L
Oncol Res; 2024; 32(4):659-678. PubMed ID: 38560572
[No Abstract] [Full Text] [Related]
6. Focused ultrasound-mediated blood-brain barrier opening is safe and feasible with moderately hypofractionated radiotherapy for brainstem diffuse midline glioma.
Tazhibi M; McQuillan N; Wei HJ; Gallitto M; Bendau E; Webster Carrion A; Berg X; Kokossis D; Zhang X; Zhang Z; Jan CI; Mintz A; Gartrell RD; Syed HR; Fonseca A; Pavisic J; Szalontay L; Konofagou EE; Zacharoulis S; Wu CC
J Transl Med; 2024 Mar; 22(1):320. PubMed ID: 38555449
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
[TBL] [Abstract] [Full Text] [Related]
8. p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme.
Meng J; Qian W; Yang Z; Gong L; Xu D; Huang H; Jiang X; Pu Z; Yin Y; Zou J
BMC Cancer; 2024 Mar; 24(1):317. PubMed ID: 38454344
[TBL] [Abstract] [Full Text] [Related]
9. Clinical features and impact of p53 status on sporadic mismatch repair deficiency and Lynch syndrome in uterine cancer.
Kato MK; Fujii E; Asami Y; Momozawa Y; Hiranuma K; Komatsu M; Hamamoto R; Ebata T; Matsumoto K; Ishikawa M; Kohno T; Kato T; Yoshida H; Shiraishi K
Cancer Sci; 2024 May; 115(5):1646-1655. PubMed ID: 38433331
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathological and molecular landscape of 5-year IDH-wild-type glioblastoma survivors: A multicentric retrospective study.
Miele E; Anghileri E; Calatozzolo C; Lazzarini E; Patrizi S; Ciolfi A; Pedace L; Patanè M; Abballe L; Paterra R; Maddaloni L; Barresi S; Mastronuzzi A; Petruzzi A; Tramacere I; Farinotti M; Gurrieri L; Pirola E; Scarpelli M; Lombardi G; Villani V; Simonelli M; Merli R; Salmaggi A; Tartaglia M; Silvani A; DiMeco F; Calistri D; Lamperti E; Locatelli F; Indraccolo S; Pollo B
Cancer Lett; 2024 Apr; 588():216711. PubMed ID: 38423245
[TBL] [Abstract] [Full Text] [Related]
11. Development and validation of a 23-gene expression signature for molecular subtyping of medulloblastoma in a long-term Chinese cohort.
Wang Y; Huang J; Yin X; Xu Q; Sun Y; Yao Y; Xiong J
Acta Neurochir (Wien); 2024 Feb; 166(1):72. PubMed ID: 38329556
[TBL] [Abstract] [Full Text] [Related]
12. Molecular signature of stem-like glioma cells (SLGCs) from human glioblastoma and gliosarcoma.
Zechel C; Loy M; Wegner C; Dahlke E; Soetje B; Baehr L; Leppert J; Ostermaier JJ; Lueg T; Nielsen J; Elßner J; Willeke V; Marzahl S; Tronnier V; Madany Mamlouk A
PLoS One; 2024; 19(2):e0291368. PubMed ID: 38306361
[TBL] [Abstract] [Full Text] [Related]
13. Rise of oligodendroglioma hypermutator phenotype from a subclone harboring tp53 mutation after TMZ treatment.
Higuchi F; Uzuka T; Matsuda H; Sumi T; Iwata K; Namatame T; Shin M; Akutsu H; Ueki K
Brain Tumor Pathol; 2024 Apr; 41(2):80-84. PubMed ID: 38294664
[TBL] [Abstract] [Full Text] [Related]
14. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
15. A single-institution retrospective exploratory analysis on the effectiveness and safety of lenvatinib plus pembrolizumab for advanced endometrial cancer: insights from ProMisE molecular classification system.
Chiba Y; Kagabu M; Osakabe M; Ito R; Sato S; Takatori E; Kaido Y; Nagasawa T; Shoji T; Yanagawa N; Baba T
Jpn J Clin Oncol; 2024 Apr; 54(4):424-433. PubMed ID: 38251744
[TBL] [Abstract] [Full Text] [Related]
16. Multi-omics analyses of choroid plexus carcinoma cell lines reveal potential targetable pathways and alterations.
Hesham D; On J; Alshahaby N; Amer N; Magdeldin S; Okada M; Tsukamoto Y; Hiraishi T; Imai C; Okuda S; Wakai T; Kakita A; Oishi M; El-Naggar S; Natsumeda M
J Neurooncol; 2024 Jan; 166(1):27-38. PubMed ID: 38190092
[TBL] [Abstract] [Full Text] [Related]
17. Clinical characteristics and prognostic factors of surgical treatment in children with brainstem tumor.
He YZ; Zhou Q; Deng WY; Huang LY; Lu YY; Ruan YY; Du H
Eur Rev Med Pharmacol Sci; 2023 Nov; 27(22):10926-10934. PubMed ID: 38039022
[TBL] [Abstract] [Full Text] [Related]
18. General Clinico-Pathological Characteristics in Glioblastomas in Correlation with p53 and Ki67.
Sipos TC; Kövecsi A; Ovidiu-Ioan Ș; Zsuzsánna P
Medicina (Kaunas); 2023 Oct; 59(11):. PubMed ID: 38003967
[No Abstract] [Full Text] [Related]
19. Clinical characteristics and prognostic factors of solitary and multiple adult gliomas: a retrospective study based on propensity score matching.
Huang R; Wu H; Lu X; Sun X
Eur Rev Med Pharmacol Sci; 2023 Nov; 27(21):10481-10498. PubMed ID: 37975372
[TBL] [Abstract] [Full Text] [Related]
20. Comparative Analysis of IDH Wild-Type Multifocal and Unifocal Glioblastomas: Prognostic Factors and Survival Outcomes in Focus.
Habiboglu R; Kayali I; Saricanbaz I; Tezcan Y
Turk Neurosurg; 2023; 33(6):1126-1131. PubMed ID: 37846543
[TBL] [Abstract] [Full Text] [Related]
[Next]
